Your browser doesn't support javascript.
loading
Prospective derivation of a living organoid biobank of colorectal cancer patients.
van de Wetering, Marc; Francies, Hayley E; Francis, Joshua M; Bounova, Gergana; Iorio, Francesco; Pronk, Apollo; van Houdt, Winan; van Gorp, Joost; Taylor-Weiner, Amaro; Kester, Lennart; McLaren-Douglas, Anne; Blokker, Joyce; Jaksani, Sridevi; Bartfeld, Sina; Volckman, Richard; van Sluis, Peter; Li, Vivian S W; Seepo, Sara; Sekhar Pedamallu, Chandra; Cibulskis, Kristian; Carter, Scott L; McKenna, Aaron; Lawrence, Michael S; Lichtenstein, Lee; Stewart, Chip; Koster, Jan; Versteeg, Rogier; van Oudenaarden, Alexander; Saez-Rodriguez, Julio; Vries, Robert G J; Getz, Gad; Wessels, Lodewyk; Stratton, Michael R; McDermott, Ultan; Meyerson, Matthew; Garnett, Mathew J; Clevers, Hans.
Afiliación
  • van de Wetering M; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Cancer Genomics and University Medical Center, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), 3584 CT Utrecht, the Netherlands.
  • Francies HE; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Francis JM; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Bounova G; Computational Cancer Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Iorio F; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridge CB10 1SA, UK.
  • Pronk A; Department of Surgery, Diakonessenhuis, 3582 KE Utrecht, the Netherlands.
  • van Houdt W; Department of Surgery, Diakonessenhuis, 3582 KE Utrecht, the Netherlands.
  • van Gorp J; Department of Pathology, Diakonessenhuis, 3582 KE Utrecht, the Netherlands.
  • Taylor-Weiner A; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Kester L; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Cancer Genomics and University Medical Center, 3584 CT Utrecht, the Netherlands.
  • McLaren-Douglas A; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Blokker J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Cancer Genomics and University Medical Center, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), 3584 CT Utrecht, the Netherlands.
  • Jaksani S; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Cancer Genomics and University Medical Center, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), 3584 CT Utrecht, the Netherlands.
  • Bartfeld S; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Cancer Genomics and University Medical Center, 3584 CT Utrecht, the Netherlands.
  • Volckman R; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.
  • van Sluis P; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.
  • Li VS; Division of Stem Cell Biology and Developmental Genetics, MRC National Institute for Medical Research, The Ridgeway, Mill Hill, London NW7 1AA, UK.
  • Seepo S; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Sekhar Pedamallu C; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Cibulskis K; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Carter SL; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • McKenna A; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Lawrence MS; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Lichtenstein L; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Stewart C; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Koster J; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.
  • Versteeg R; Department of Oncogenomics, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.
  • van Oudenaarden A; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Cancer Genomics and University Medical Center, 3584 CT Utrecht, the Netherlands.
  • Saez-Rodriguez J; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Cambridge CB10 1SA, UK.
  • Vries RG; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Cancer Genomics and University Medical Center, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), 3584 CT Utrecht, the Netherlands.
  • Getz G; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Wessels L; Computational Cancer Biology, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.
  • Stratton MR; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • McDermott U; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.
  • Meyerson M; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
  • Garnett MJ; Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. Electronic address: mg12@sanger.ac.uk.
  • Clevers H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW), Cancer Genomics and University Medical Center, 3584 CT Utrecht, the Netherlands; Foundation Hubrecht Organoid Technology (HUB), 3584 CT Utrecht, the Netherlands. Electronic address: h.clevers@hubrecht.eu.
Cell ; 161(4): 933-45, 2015 May 07.
Article en En | MEDLINE | ID: mdl-25957691
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ensayos de Selección de Medicamentos Antitumorales / Neoplasias Colorrectales / Organoides / Bancos de Muestras Biológicas Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Cell Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Ensayos de Selección de Medicamentos Antitumorales / Neoplasias Colorrectales / Organoides / Bancos de Muestras Biológicas Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Cell Año: 2015 Tipo del documento: Article País de afiliación: Países Bajos